Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Tempest Therapeutics, Inc. (TPST) had Cash Flow from Financial Activities of $-0.72M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-10.86M |
|
-- |
|
-- |
|
$10.94M |
|
$-10.94M |
|
$0.08M |
|
$-10.86M |
|
$-10.86M |
|
$-10.86M |
|
$-10.86M |
|
$-10.86M |
|
$-10.86M |
|
$-10.94M |
|
$-10.87M |
|
3.44M |
|
3.44M |
|
$-3.16 |
|
$-3.16 |
|
| Balance Sheet Financials | |
$22.43M |
|
$0.82M |
|
$9.73M |
|
$32.16M |
|
$13.18M |
|
-- |
|
$7.85M |
|
$21.03M |
|
$11.13M |
|
$11.13M |
|
$11.13M |
|
3.52M |
|
| Cash Flow Statement Financials | |
$-8.04M |
|
-- |
|
|
Cash Flow from Financial Activities |
$-0.72M |
$30.71M |
|
$21.95M |
|
$-8.76M |
|
$1.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.70 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.04M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-97.55% |
|
-97.55% |
|
-33.76% |
|
-97.55% |
|
$3.16 |
|
$-2.34 |
|
$-2.34 |
|